GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Current Ratio

AP Biosciences (ROCO:6945) Current Ratio : 24.80 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. AP Biosciences's current ratio for the quarter that ended in Dec. 2023 was 24.80.

AP Biosciences has a current ratio of 24.80. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for AP Biosciences's Current Ratio or its related term are showing as below:

ROCO:6945' s Current Ratio Range Over the Past 10 Years
Min: 24.8   Med: 48.45   Max: 242.1
Current: 24.8

During the past 4 years, AP Biosciences's highest Current Ratio was 242.10. The lowest was 24.80. And the median was 48.45.

ROCO:6945's Current Ratio is ranked better than
94.61% of 1540 companies
in the Biotechnology industry
Industry Median: 3.77 vs ROCO:6945: 24.80

AP Biosciences Current Ratio Historical Data

The historical data trend for AP Biosciences's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Current Ratio Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Current Ratio
70.22 26.67 242.10 24.80

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Current Ratio Get a 7-Day Free Trial 26.67 - 242.10 39.78 24.80

Competitive Comparison of AP Biosciences's Current Ratio

For the Biotechnology subindustry, AP Biosciences's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AP Biosciences's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AP Biosciences's Current Ratio distribution charts can be found below:

* The bar in red indicates where AP Biosciences's Current Ratio falls into.



AP Biosciences Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

AP Biosciences's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=765.642/30.875
=24.80

AP Biosciences's Current Ratio for the quarter that ended in Dec. 2023 is calculated as

Current Ratio (Q: Dec. 2023 )=Total Current Assets (Q: Dec. 2023 )/Total Current Liabilities (Q: Dec. 2023 )
=765.642/30.875
=24.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AP Biosciences  (ROCO:6945) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


AP Biosciences Current Ratio Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AP Biosciences (ROCO:6945) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences (ROCO:6945) Headlines

No Headlines